Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?

To: Apache Indian who wrote (254)	2/3/1998 9:32:00 PM
From: Doug Markle	Read Replies (2) \| Respond to of 1494

Delisting RICHMOND, Calif., Feb. 3 /PRNewswire/ -- Neurobiological Technologies, Inc. (formerly Nasdaq SmallCap symbol: NTIIC) reported that the company's common stock was delisted from The Nasdaq SmallCap Market effective the close of business Tuesday, February 3, 1998. The company did not meet the financial conditions necessary to remain listed on The Nasdaq Stock Market(SM). Neurobiological Technologies, Inc. (NTI) has been informed that its common stock will be eligible for quotation on the OTC-Bulletin Board(R) beginning Wednesday, February 4, 1998 under the symbol NTII. ''While the stock's trading forum is important, I believe that NTI's recently announced data from a controlled Phase II human clinical trial of Memantine is more significant,'' said Paul E. Freiman, president and chief executive officer. ''We are now in discussions with potential individual and institutional investors in an effort to obtain funding for continued development of the company's product candidates.''